Home | Ge-Bu

Opioids for chronic pain: scarcely any added value

dr AJFA Kerst, dr HJEM Janssens
Nr 8|2019 (53)|Main article

The unmistakable increase in the number of prescriptions for opioids (with their associated risks of addiction and adverse effects) should be a subject for debate. There is, or at least appears to ...

In short Read article

Health apps for natural contraception: old wine in new bottles

dr H.I.J. Wildschut
Nr 6-7|2019 (53)|Page 61-65|Main article

Apps such as NaturalCycles® are being used by many women around the world as a natural, non-medical method of contraception. These apps are medical devices, which in principle have to meet the sam ...

In short Read article

Off-label use of mirtazapine to treat insomnia

mw drs M.A.E. Nieuwhof
Nr 6-7|2019 (53)|Page 66-68|New

The antidepressant mirtazapine (Remeron®) is increasingly used by patients suffering from insomnia. However, this usage is not based on evidence of effectivity from randomised studies. At best, th ...

In short Read article

Hormonal contraception not a cause of depression?

mw S. van der Heijden MSc, prof. dr F.M. Helmerhorst, dr I.M. van Vliet, drs C.J.H de Vries
Nr 5|2019 (53)|Page 54-60|Main article

Little research has been done into the association between the use of hormonal contraception and depression. The few studies that have been done have suffered from methodological shortcomings, and ...

In short Read article

No place for antipsychotics in the treatment of delirium in hospitalised patients?

dr H.J.E.M. Janssens
Nr 5|2019 (53)|Page 49-53|New

For decades now, antipsychotics have been used to treat delirium, including the only agent authorised for this indication in the Netherlands, haloperidol. Once more, however, research has found no ...

In short Read article

New drug: dimethyl fumarate to treat psoriasis

dr L.M.L. Stolk
Nr 4|2019 (53)|Page 44-47|New

Dimethyl fumarate (Skilarence^®) was newly registered in 2017 for the treatment of psoriasis. This is not a new drug, as it has been available as an unlicensed product for decades. After the regist ...

In short Read article

Prolonged-release Metformin

mw D.M. Corbijn, BSc, mw drs M.A.E. Nieuwhof
Nr 4|2019 (53)|Page 38-43|Main article

Metformin, Glucient^® SR (Consilient Health), prolonged-release tablets 500, 750 and 1000 mg
In theory, prolonged-release metformin as a diabetes drug should cause fewer gastro-intestinal adverse ...

In short Read article

Hydrochlorothiazide and skin cancer: a debatable warning?

mw S. van der Heijden MSc
Nr 3|2019 (53)|Page 32-36|New

Dutch care providers and patients were confronted in October 2018 by a nationwide warning about a “slightly increased” risk of squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) when usi ...

In short Read article

Search

Recent articles

Opioids for chronic pain: scarcely any added value

Health apps for natural contraception: old wine in new bottles

Off-label use of mirtazapine to treat insomnia

Hormonal contraception not a cause of depression?

No place for antipsychotics in the treatment of delirium in hospitalised patients?

New drug: dimethyl fumarate to treat psoriasis

Prolonged-release Metformin

Hydrochlorothiazide and skin cancer: a debatable warning?